Botox market is estimated to be over US$ 4800 million in 2019. It is anticipated to grow at 7.5% CAGR from 2019 to 2030.
Increasing inclination towards cosmetic procedures for several aesthetic treatments, growing adoption rate by geriatric individuals, and rising preference of minimally invasive & noninvasive aesthetic procedures are anticipated to boost the growth of botox market over the forecast period. Moreover, extensive research & development and awareness programs conducted by major companies across the globe for introducing new botox products is expected to contribute in increasing use of botox injections for several non-surgical cosmetic procedures. For instance, in June 2019; Evolus, Inc. launched #NEWTOX NOW consumer conversion program for rapid adoption of Jeuveau. It is a purified botulinum toxin type A formulation used for the temporary improvement in appearance of moderate to severe glabellar lines in adults.
Major Key Players of the Botox Market are:
Allergan, Ipsen Group, Medytox, Merz Pharma, HUGEL, US WorldMeds, Galderma Laboratories, L.P., Revance Therapeutics, Inc, Eisai Co., Ltd. and DAEWOONG CO.LTD among others.
No comments:
Post a Comment